Stay updated on SubQ Efgartigimod in CIDP Clinical Trial

Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor internal update to the trial entry rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-05-19T12:30:33.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Taiwan enrollment location updated: Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the study's locations.
    Difference
    0.0%
    Check dated 2026-05-05T05:39:19.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new Revision: v3.5.3 was added, replacing the previous Revision: v3.5.2. This indicates a small metadata update to the page, not affecting study content.
    Difference
    0.0%
    Check dated 2026-04-27T20:11:18.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2. Previous revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-20T16:26:12.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    CIDP is added as a listed condition, and a Genetic and Rare Diseases Information Center resource link is included.
    Difference
    0.1%
    Check dated 2026-03-30T02:12:59.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    - Added Naples, Italy 80131 and removed Napoli, Italy 80131 from the locations list. - Publication section updated with the Lancet Neurology ADHERE study citation and DOI; Revision updated to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-22T22:43:46.000Z thumbnail image

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.